ANDAORALTABLET
Approved
Jan 2003
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
RIMANTADINE HYDROCHLORIDE (rimantadine hydrochloride) by Molecular Devices is mechanism of action the mechanism of action of rimantadine is not fully understood. First approved in 2003.
Drug data last refreshed 19h ago
Mechanism of Action
Mechanism of Action The mechanism of action of rimantadine is not fully understood. Rimantadine appears to exert its inhibitory effect early in the viral replicative cycle, possibly inhibiting the uncoating of the virus. Genetic studies suggest that a virus protein specified by the virion M 2 gene…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Molecular Devices
Worked on RIMANTADINE HYDROCHLORIDE at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.